These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3943010)

  • 61. [Leg ulcer in a patient treated with hydroxyurea for polycythemia vera].
    Hanchi I; Zeglaoui F; Ezzine N; Daoud L; Karoui M; Fazaa B; Ridha Kamoun M
    Presse Med; 2006; 35(7-8):1174-6. PubMed ID: 16840894
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.
    Kiladjian JJ; Chevret S; Dosquet C; Chomienne C; Rain JD
    J Clin Oncol; 2011 Oct; 29(29):3907-13. PubMed ID: 21911721
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hydroxyurea-induced fever and hepatitis.
    Westerman DA; Schwarer A; Grigg AP
    Aust N Z J Med; 1998 Oct; 28(5):657-9. PubMed ID: 9847957
    [No Abstract]   [Full Text] [Related]  

  • 64. [Cutaneous side effects of hydroxyurea treatment for polycythemia vera].
    Hoff NP; Akanay-Diesel S; Pippirs U; Schulte KW; Hanneken S
    Hautarzt; 2009 Oct; 60(10):783-7. PubMed ID: 19756436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Treatment of polycythemia vera].
    Dulíček P
    Vnitr Lek; 2018; 64(10):955-960. PubMed ID: 30590943
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester.
    Pata O; Tok CE; Yazici G; Pata C; Oz AU; Aban M; Dilek S
    Am J Perinatol; 2004 Apr; 21(3):135-7. PubMed ID: 15085495
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.
    Sirhan S; Busque L; Foltz L; Grewal K; Hamm C; Laferriere N; Laneuville P; Leber B; Liew E; Olney HJ; Prchal J; Porwit A; Gupta V
    Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):715-27. PubMed ID: 26433906
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis.
    Ferrari A; Carobbio A; Masciulli A; Ghirardi A; Finazzi G; De Stefano V; Vannucchi AM; Barbui T
    Haematologica; 2019 Dec; 104(12):2391-2399. PubMed ID: 31123026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An exceptional case of renal artery restenosis in a patient with polycythaemia vera.
    Gavriilaki E; Sampanis N; Kavlakoudis C; Papaioannou G; Vasileiou S
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):904-6. PubMed ID: 24991947
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera.
    Ellis AK; Lee DH
    Am J Hematol; 2002 Nov; 71(3):237-8. PubMed ID: 12410589
    [No Abstract]   [Full Text] [Related]  

  • 71. Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
    Kiladjian JJ; Rain JD; Bernard JF; Briere J; Chomienne C; Fenaux P
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):417-21. PubMed ID: 16810617
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
    Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
    Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transition of polycythemia vera to chronic neutrophilic leukemia.
    Higuchi T; Oba R; Endo M; Harada H; Mori H; Niikura H; Omine M; Fujita K
    Leuk Lymphoma; 1999 Mar; 33(1-2):203-6. PubMed ID: 10194140
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An unusual case of toe ulceration.
    Lankipalli R; Konkle B; Mohler ER
    Vasc Med; 2006 Feb; 11(1):35-7. PubMed ID: 16669411
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Experience with the 5-hydroxyurea therapy of polycythemia rubra vera].
    Nagy G; Szegedi J; Petrányi G
    Orv Hetil; 1972 Jun; 113(27):1601-3. PubMed ID: 5040981
    [No Abstract]   [Full Text] [Related]  

  • 76. Polycythemia Vera.
    Spivak JL
    Curr Treat Options Oncol; 2018 Mar; 19(2):12. PubMed ID: 29516275
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Huge post-operative ulcer following hydroxyurea therapy in a patient with polycythemia vera.
    Yokota K; Tasaka T; Iwata K; Ogawa H; Nakano M; Seki K; Ogura S
    Haematologica; 2003 Dec; 88(12):ECR36. PubMed ID: 14688009
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Can pegylated interferon improve the outcome of polycythemia vera patients?
    Crisà E; Cerrano M; Beggiato E; Benevolo G; Lanzarone G; Manzini PM; Borchiellini A; Riera L; Boccadoro M; Ferrero D
    J Hematol Oncol; 2017 Jan; 10(1):15. PubMed ID: 28086927
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera.
    Johansson P; Andréasson B
    Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The cutaneous side-effects of hydroxyurea.
    Young HS; Khan AS; Kendra JR; Coulson IH
    Clin Lab Haematol; 2000 Aug; 22(4):229-32. PubMed ID: 11012636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.